top of page

JYNARQUE – Otsuka America

This is the first and only FDA-approved treatment proven to slow kidney function decline in adults who are at risk for rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). The patient testimonials that appear on the site are inspiring stories of how the drug has given hope to a new generation of ADPKD sufferers. Visit
to see the stories.

JYNARQUE home page.png
bottom of page